Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
about
Beyond CA125: the coming of age of ovarian cancer biomarkersMannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibodyDesigned auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo.Yeast surface display for protein engineering and characterizationEfficient recovery of high-affinity antibodies from a single-chain Fab yeast display library.Assessing lead time of selected ovarian cancer biomarkers: a nested case-control studyRapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor.Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.High-throughput biotinylation of proteins.Novel system for in vivo biotinylation and its application to crab antimicrobial protein scygonadin.Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptorEfficient construct of a large and functional scFv yeast display library derived from the ascites B cells of ovarian cancer patients by three-fragment transformation-associated recombination.Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discoveryEffects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Creation and Evaluation of a Single-chain Antibody Tetramer that Targets Brain Endothelial Cells.Antibody Fragments as Probe in Biosensor Development.Evidence for PII with NAGK interaction that regulates Arg synthesis in the microalga Myrmecia incisa in response to nitrogen starvation.Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.
P2860
Q24651567-F9F93568-5410-4A3B-89E9-5D12E188943CQ28478285-DFDBEC36-1DE4-4647-85E9-24DC9FB661C7Q30492713-B2771F7C-4DA4-49E1-A2B5-9A099FD1180FQ33299124-1EE7D2DD-E580-46EF-A015-387E105EE7D5Q33431668-F1AF6D88-F798-4798-A239-85163E06E211Q33574039-FC2A231C-C4EB-4949-952E-8F90AA4EDF41Q33691051-BE8A1B58-527D-4E69-BBC4-E60E423D453FQ34030602-07ACC583-85C3-4689-BC58-7777BE35FB3FQ34260503-6F2D97A9-A677-41B5-B3C6-DDACE7326527Q34347703-F8A896EC-FCDE-4E6F-A790-CDB60BC15F0DQ34895083-90D5251B-6FA3-45C4-BB9E-AB76258717A1Q35570231-E15D5EDE-A8DB-41B4-908A-AE0A209D1532Q35659518-2268416F-B493-4E50-9D70-50940242FAFCQ35802193-53C23BB7-BAC4-41B0-93C5-EDC80782A84CQ35897306-1149104E-E4DE-46E7-BCC7-D4EAA06843ACQ36216991-183729B1-AD37-4B88-8A90-360DF2455B90Q36823332-A76AABEE-61EE-4EF4-A50B-34DD1DC415B2Q37076713-C6C14536-F79C-42CF-93BB-4C60213EB6C6Q37348306-272F4D36-AF1D-4E85-A5A0-5AD2F53C1ADFQ37375504-5874C8BE-285F-4A8C-8382-2787B83A52B0Q37645592-A5AC170F-F1CE-4A49-A6F7-C5F6034E61F1Q39016494-4DB7980E-B30B-4B9B-9FC1-00338F2B383CQ47132506-2573DB50-F883-4D47-9890-3B8E03CA7CF3Q47193015-305A7567-3C96-4AB0-AD52-7934BA1E68CC
P2860
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@ast
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@en
type
label
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@ast
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@en
prefLabel
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@ast
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@en
P2093
P2860
P1476
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.
@en
P2093
Barbara Garvik
Nathalie Scholler
Nicole Urban
Shaoyi Jiang
Travis Quarles
P2860
P304
P356
10.1016/J.JIM.2006.10.003
P577
2006-10-30T00:00:00Z